retatrutide triple agonist glp-1 gip glucagon phase 2 results Efficacy and safety of retatrutide, a GIP, GLP-1, and receptor agonist, in people with type diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, 3 TrimRX | GLP-1 vs GIP:
Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26


01053-X/asset/826330f0-5581-4d6d-8f45-2192fe6ac242/main.assets/gr2_lrg.jpg)







![How Stonehenge Health® Saved $1M in 1 Year by Switching to ShipBob Plus [Case Study]](https://www.shipbob.com/wp-content/uploads/2026/03/e01edfb85c6b94277af4e3d87484d747-e1773694612896.webp?w=1280)















